Wealthspire Advisors (Maryland)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-276	Closed	-$4K	–	2394
2019 Q1	$4K	Buy	276 +26	+10%	+$332	﹤0.01%	1958
2018 Q4	$3K	Sell	250 -146	-37%	-$2.03K	﹤0.01%	2029
2018 Q3	$10K	Hold	396	–	–	﹤0.01%	1540
2018 Q2	$8K	Hold	396	–	–	﹤0.01%	1642
2018 Q1	$7K	Buy	396 +13	+3%	+$217	﹤0.01%	1707
2017 Q4	$5K	Buy	383 +142	+59%	+$1.92K	﹤0.01%	1865
2017 Q3	$4K	Buy	241 +9	+4%	+$150	﹤0.01%	1881
2017 Q2	$4K	Buy	+232	New	+$3.53K	﹤0.01%	1865

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wealthspire Advisors (Maryland)'s MNTA Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2019, closing a stake of 276 shares — an estimated $4K sold.

Wealthspire Advisors (Maryland) first reported a position in MNTA in Q2 2017 and held it in 8 quarters. The position peaked at $10K in Q3 2018. 155 funds tracked by Wall St. Rank hold MNTA as of Q2 2019.

Wealthspire Advisors (Maryland) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 276 Momenta Pharmaceuticals, Inc. shares in Q2 2019, an estimated $4K.
Wealthspire Advisors (Maryland) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2017 and held it in 8 quarters.
Wealthspire Advisors (Maryland)'s Momenta Pharmaceuticals, Inc. position peaked at $10K in Q3 2018.
155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.